3-Nitropyrazole compounds and anti-microbial compositions
    5.
    发明授权
    3-Nitropyrazole compounds and anti-microbial compositions 失效
    3-硝基吡唑化合物和抗微生物组合物

    公开(公告)号:US4105772A

    公开(公告)日:1978-08-08

    申请号:US744215

    申请日:1976-11-22

    CPC分类号: C07D231/16

    摘要: New 3-nitropyrazole compounds of the formula: ##STR1## wherein R.sub.1 is lower alkyl;R.sub.2 is hydrogen or lower alkyl;R.sub.3 is cyano, carboxyl or lower alkoxycarbonyl or the radical --CO--NR.sub.4 R.sub.5, in whichR.sub.4 is hydrogen or hydroxyl, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, thiocarbamoyl, ureido, thioureido, hydroxyphenyl, picolyl or is a lower alkyl, alkenyl or cycloalkyl radical substituted, if desired, by a cyano, hydroxyl, pyrrolidino, piperidino, amino, lower alkylamino, lower dialkylamino or lower acylamino substituent andR.sub.5 is a hydrogen atom or a lower alkyl radical orR.sub.4 and R.sub.5 together represent a lower alkylene bridge;And the pharmacologically compatible salts thereof, are outstandingly effective as anti-microbial agents, particularly systemically and in the urinary tract.

    摘要翻译: 新的具有下式的3-硝基吡唑化合物:其中R 1是低级烷基; R2是氢或低级烷基; R3是氰基,羧基或低级烷氧基羰基或基团-CO-NR4R5,其中R4是氢或羟基,氨基甲酰基,烷基氨基甲酰基,二烷基氨基甲酰基,硫代氨基甲酰基,脲基,硫脲基,羟基苯基,吡啶甲基或是低级烷基,烯基或环烷基取代 如果需要,通过氰基,羟基,吡咯烷子基,哌啶子基,氨基,低级烷基氨基,低级二烷基氨基或低级酰基氨基取代基,R 5是氢原子或低级烷基,或者R 4和R 5一起代表低级亚烷基桥; 并且其药理学兼容的药物作为抗微生物剂,特别是在系统性和全球性的治疗中是非常有效的。

    Tricyclic aminoalkyl derivatives
    6.
    发明授权
    Tricyclic aminoalkyl derivatives 失效
    三环氨基烷基衍生物

    公开(公告)号:US4070373A

    公开(公告)日:1978-01-24

    申请号:US291426

    申请日:1972-09-22

    摘要: Novel tricyclic aminoalkyl derivatives are disclosed which are characterized by valuable pharmacological activities and namely by cardiac and circulatory activities. The tricyclic aminoalkyl derivatives are compounds of the formula: ##STR1## wherein X is an oxygen or a sulfur atom, a saturated or unsaturated, straight chain or branched alkylene group containing up to 3 carbon atoms, an oxymethylene, thiamethylene or thiaethylene group or a valency bond, R.sub.1 is hydrogen, halogen, alkyl, alkoxy or trifluoromethyl, R.sub.2 is hydrogen or hydroxyl, R.sub.3 is hydrogen or together with R.sub.2 represents a further valency bond, R.sub.4 and R.sub.5 which may be the same or different are each hydrogen or lower alkyl, A is alkylene which is substituted by an optionally acylated hydroxyl group, Y is an oxygen or sulfur atom or an optionally alkylated imino group and Z is aryl, aralkyl, cycloalkyl or cycloalkyl-alkyl which may be substituted by halogen, hydroxyl, nitro, amino, alkoxy, aralkoxy, alkyl, trifluoromethyl, alkylamino or alkylsulfonyl group, and the acid addition salts thereof with pharmacologically acceptable acids.

    摘要翻译: 公开了新颖的三环氨基烷基衍生物,其特征在于有价值的药理活性,即通过心脏和循环活性。 三环氨基烷基衍生物是下式的化合物:其中X是氧或硫原子,含有至多3个碳原子的饱和或不饱和的直链或支链亚烷基,亚甲基,亚亚甲基或亚硫代亚乙基或 化合键,R 1是氢,卤素,烷基,烷氧基或三氟甲基,R 2是氢或羟基,R 3是氢或与R 2一起代表另外的价键,可以相同或不同的R 4和R 5各自是氢或低级烷基 A是被任意酰化的羟基取代的亚烷基,Y是氧或硫原子或任选烷基化的亚氨基,Z是可以被卤素,羟基,硝基取代的芳基,芳烷基,环烷基或环烷基 - 烷基, 氨基,烷氧基,芳烷氧基,烷基,三氟甲基,烷基氨基或烷基磺酰基,及其与药理学上可接受的酸的酸加成盐。